In addition, staining for additional markers may also provide more comprehensive assessment; e.g. the addition of CD8+ could provide a biopsy‐based surrogate comparable to the Immunoscore 8, whereas staining for markers associated with tumour‐associated fibroblasts may improve sensitivity and specificity of the biopsy assessment of TSP. This evidence concerns the gene CD8A and neoplasm.